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Background: Complementary and alternative medicine (CAM) use in patients with IBD is on the increase. Patients
report they use CAM when their condition is unresponsive to conventional medication or when they suffer from
side-effects, negative stress and disease-related concerns. CAM use may improve patients’ well-being but it can also
lead to side-effects and interactions with conventional medications. Research on attitudes to and experiences of
CAM among healthcare professionals working with IBD patients is not well studied. Studies in this area could lead
to enhanced awareness of and improved communication about CAM between care staff and IBD patients. The aim
of this study was to explore IBD professionals’ attitudes to and experience of CAM.
Methods: Sixteen physicians and nurses, 26–70 years old, who had worked with IBD patients for 1–42 years, were
recruited. Semi-structured qualitative interviews were conducted. Qualitative content analysis was performed.
Results: Participants stated patients used CAM to improve their well-being generally and there conditions specifically.
Participants had a positive attitude towards CAM and respected their patients’ decision to use it, but reported a lack
of CAM knowledge. They required education about CAM to be able to meet patients’ needs and provide adequate
information. The result of this study indicates that there is a need for CAM education to be implemented in nursing
and medical school.
Conclusions: All participants had experience of IBD patients who had used CAM in an attempt to achieve
improvement and well-being. Attitudes to CAM were mainly positive, although a problematic aspect was lack of
knowledge and evidence in relation to CAM. Implementing CAM education in nursing and medical school will
allow healthcare professionals to gain an understanding of therapies widely used by patients with IBD. In clinical
practice, using a standard questionnaire regarding CAM use allow healthcare professionals to better understand
their patients’ wishes and current CAM use.
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Ulcerative colitis (UC) and Crohn’s disease (CD) are disab-
ling, chronic relapsing inflammatory bowel diseases (IBD).
Symptoms are diarrhoea, often with blood or mucus dis-
charge, abdominal pain, weight loss, malabsorption, mal-
nutrition and fatigue. Manifestations from other organ
systems such as joints, eyes, skin, liver and bile ducts may
also occur. The cause of IBD is unknown and there is no* Correspondence: annelie.lindberg@ds.se
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reproduction in any medium, provided the orcure, although several therapeutic advances have been
made in recent years. The complexity of IBD treatment
has increased, and the use of new immunomodulating
agents is escalating. The main issue is to combine therap-
ies with minimal side effects and focus on optimising
quality of life [1,2]. IBD and its medical treatment have a
major impact on patients’ health-related quality of life
(HRQOL) [3-5], which may be the reason for their interest
in complementary and alternative medicine (CAM) [6].
The World Health Organization (WHO) defines CAM
as a broad range of healthcare practices that are not part
of a country’s tradition and not integrated into the mainal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tive medical systems, mind-body interventions, biologically
based therapies, manipulative and body-based methods and
energy therapies [8]. Complementary medicine refers to the
use of CAM in combination with conventional medicine,
while alternative medicine implies the use of CAM instead
of conventional medicine. Integrative medicine combines
both conventional and evidence based CAM treatment [8].
People are willing to spend a great deal of money on
CAM treatment [9,10]. In a review Harris et al. [11] showed
that CAM was frequently used by the general population
in 15 countries. In fact the prevalence of all types of CAM
use ranged from 9% to 76%. CAM use has increased in
Denmark, Norway and Sweden from 22%-33% to 34%-49%
[12]. In Norway and Denmark, half and one third of hos-
pitals respectively offer CAM treatments to patients [13].
It is well known that patients with chronic diseases use
CAM [14,15], including IBD [16-19]. In one study con-
ducted at an IBD centre in Stockholm, Sweden, CAM use
was 32% [20].
There are various reasons why IBD patients turn to CAM,
e.g. they may be unresponsive to or suffer side-effects from
conventional treatment or have heard/read that CAM can
be helpful [21]. Individuals suffering from IBD want to regain
control over their illness [22] and appreciate the fact that
CAM focuses on the whole person [19,23]. Intensive long-
term corticosteroid therapy [24], negative stress and disease-
related concerns [23] have been found to correlate with
CAM use among IBD patients. Patients do not tell their
physician about using CAM if the physicians do not
suggest it [25] and it has been found that the decision to
inform the physician about CAM use depends on the
quality of the patient-physician relationship [21].
CAM treatments are not without risks, for example,
CAM can interact with conventional medication [26].
CAM treatments such as noni juice (Morinda citrifolia)
[27,28] or other herbal medicinal products can be toxic
to the liver [29], which is important to know, given
some IBDs may be associated with disorders in the liver
and biliary tract [30-32]. Thus, knowledge of patients’
use of CAM, will allow healthcare professionals to bet-
ter monitor patients and their responses to treatments.
In 2006, an EU directive on “traditional herbal medi-
cinal products” was incorporated into Swedish legisla-
tion. Coupled with the fact that patients with chronic
diseases use CAM, this suggests healthcare professionals
to be knowledgeable about such products [33]. Healthcare
in Sweden is regulated by the Patient Safety Act [34],
which sets out the duties and responsibilities of health-
care professionals. A healthcare professional is defined
as a person with a health qualification or a protected oc-
cupational title who provides care in a hospital or clinic.
CAM practitioners are not considered healthcare pro-
fessionals in Sweden [34].Research on IBD healthcare professionals’ attitudes to
and experience of CAM is not well studied in Sweden, so
far. However in one US study, physicians expressed sym-
pathy towards IBD patients’ use of CAM because of IBD’s
problematic etiology and management options [35], by
highlighting IBD healthcare professionals’ attitudes to and
experience of CAM, problem areas ought to be identified.
Experience is a philosophical concept and something we
constantly perceive in continuous interaction with the en-
vironment [36]. It is important to reflect on the meaning
of the experience in what you do, what happens and how
this affects your attitude. Healthcare professionals’ attitude
plays an important role in the establishment of the rela-
tionship with the patient and healthcare professionals are
responsible for their attitudinal reaction [37]. Increased
awareness and knowledge of CAM are necessary in order
to enhance communication in IBD professionals’ encoun-
ters with their patients and thereby the quality of care.
The aim of this study was to explore IBD professionals’ at-
titudes to and experience of CAM.
Methods
The design was a qualitative study with semi-structured
interviews. A qualitative perspective, content analysis, was
used to create an understanding of the phenomenon IBD
professionals’ attitudes to and experience of CAM [38,39].
Participants
The respondents were RNs and physicians recruited
from four IBD clinics in two metropolitan areas. Pur-
poseful sampling was used to obtain as much variation
as possible in terms of experience and to achieve insight
into the phenomenon, IBD professionals’ attitudes to
and experience of CAM [39]. The variables on which
purposeful sampling were based on was profession, gen-
der, age and years in IBD care.
Data collection
RNs and physicians were contacted directly at the IBD
clinics. Sixteen healthcare professionals were recruited
in accordance with the sampling framework (15–20 per-
sons). All those invited agreed to participate. The inter-
views were conducted using a semi-structured interview
guide with open-ended questions to fulfil the aim of the
study [39]. Participants were asked about their attitudes
to and experience of CAM according to their own per-
spective. No definition of CAM was given before the in-
terviews. Supportive questions were added during the
interview (What do you mean? Could you explain?) A
test interview was performed to assess the validity of the
interview guide [39]. An audit trial of this interview was
conducted by an external research group, which confirmed
credibility. The first author (AL), who has 17 years of ex-
perience as an IBD nurse, performed all interviews with the
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(LO) to ensure credibility and avoid bias [40]. The inter-
views were conducted in a separate room, and took place at
the participants’ IBD clinics, each of which lasted from 15–
50 minutes. Before the interview the participants gave their
informed consent.
Data analysis
Content analysis is a research technique for analysing
relatively unstructured data in order to arrive at replic-
able and valid conclusions from texts in their context
[38,39]. Krippendorff ’s manifest qualitative content ana-
lysis method was used, as it is appropriate for analysing
text that focuses on communication and experiences,
which is in line with the aim of the study. A core feature
of qualitative content analysis is the development of cat-
egories on the basis of similarities and differences at
various logical levels [38]. The interviews were recorded
and transcribed verbatim. In the first step, the authors
read the entire text several times in order to become fa-
miliar with it and gain a sense of the whole. Two do-
mains were recognized: description of attitudes and
description of experiences. In the next step, meaning
units corresponding to the two domains were extracted
and coded. Sentences and phrases containing informa-
tion relevant to the aim were understood as meaning
units. Each meaning unit was condensed, labelled, orga-
nised into groups and coded according to domain. This
was followed by classifying and abstracting the meaning
units into sub-categories and categories to highlight the
content. During the analysis efforts were made to remain
close to the interview text. Sub-categories and categories
were identified by moving back and forth between cat-
egories, meaning units, domains and text. Data were
analysed by the researchers and the outcomes discussed
to ensure reliability. Disagreements were debated until
consensus was reached. The researchers jointly discussed
the validity to ensure that the sub-categories and cat-
egories were mutually exclusive and exhaustive [39,40].
Ethical consideration
The study was approved by the Regional Ethical Review
Board in Stockholm. All participants were assured of
confidentiality, informed that participation was voluntary
and that they could withdraw at any time.
Results
Sixteen IBD professionals (seven physicians and nine
nurses) were interviewed. Their mean age was 49 years
(range 26–70), 11 were women and five were men. Their
mean year of clinical experience in the area of IBD was
20 years (range 1–42). The results are presented in two
domains; attitudes and experiences and each domaingenerated four categories. Each category had two to six
sub-categories (Table 1).
Attitudes
Category I. Creating trust and a good relationship with
the patient
This category included three sub-categories; strategies for
the encounter with patients, searching for information on
the patients’ behalf and a positive attitude to CAM.
The IBD professionals considered that honesty, re-
spect, creating trust and adopting an open attitude were
important strategies when encountering patients, for ex-
ample, having a dialogue with the patient, as expressed
by one of the participants:
I say to my patients, you can take what you want as
long as you inform me and that it doesn’t make you
worse in any way. (No. 3)
The informants emphasised the importance of treating
patients with respect when they informed about their
CAM use. It was also essential to adopt a respectful atti-
tude in relation to patients’ decision to use CAM in
order to create a trusting relationship.
You have to be very careful not to have a superior
attitude towards the patient and not say that it’s
nonsense and to stop taking it. That would be very
dangerous and can ruin the relationship with the
patient. (No. 2)
The healthcare professionals stressed the importance of
creating trust and a good relationship with the patients as
well as maintaining contact and assisting her/him in
searching for information about CAM. Several expressed
a positive attitude towards CAM in addition to curiosity
about and an interest in different CAM methods.
Category II. Wishing for knowledge and understanding
This category generated the sub-categories; willingness
to learn about CAM, searching for relevant education
and raising the level of awareness about and concretizing
patients’ CAM use.
It was clear that the participants wanted to learn more
about CAM. They stated that it would be interesting as
well as stimulating to learn more and be able to support
patients when they had questions about CAM treatment.
When considering our patients and their problems, it
would be very interesting to learn more. (No. 14)
The informants expressed a wish for relevant educa-
tion, mainly in the form of lectures and dialogue rather
than written information via e-mail or letter. They stated
Table 1 Overview of domains, categories and
subcategories
Domains Categories Subcategories
Attitudes Creating trust and a
good relationship with
the patient
Strategies for the encounter
with Patients
Searching for information on
patients’ behalf
A positive attitude to CAM
Wishing for knowledge
and understanding
Willingness to learn about CAM
Searching for relevant
education
Raising the level of awareness
about and concretizing
patients’ CAM use
Trust in CAM Acceptance of CAM
CAM as a complement to
conventional treatment
Untapped resource







No need of or interest in CAM
Personal definition of CAM
Reticence about CAM
Experiences Motives for CAM use Concern about side-effects of
conventional medication











The patient is searching
The patient believes in the
efficacy of CAM
The patient informs about
her/his CAM use




Personal experience of CAM
Influence of pati ents’
narratives about CAM
Experiences of friends/relatives
Professional experience of CAM
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son who provides information about CAM in an objective
manner based on competence in the area. The IBDprofessionals wanted factual and well founded knowledge
that they could communicate to their patients.
I don’t believe in mailshots, you should go and listen to
someone who provides the information in an objective
way, not some fanatic who is sold on something. (No. 2)
The informants considered it valuable to be told about
the patients’ use of CAM in order to make them aware
of and concretise their CAM use. They exemplified this
by saying that it was important to pose a direct question
to the patients about whether or not they used CAM.
Some did not routinely pose such questions and merely
asked about herbal remedies, while others only ques-
tioned patients with liver diseases, as it could be caused
by such products.
I usually put questions to patients with liver disease,
but rarely to those with IBD. (No. 12)
Category III. Trust in CAM
This category generated the sub-categories; acceptance
of CAM, CAM as a complement to conventional treat-
ment, untapped resource, right time for CAM and confi-
dence in manual therapies.
The level of acceptance of CAM varied among IBD
professionals and became higher when CAM was used
as a complement to conventional medication.
I suppose it’s okay if it’s used as a complement to
ordinary healthcare. (No. 4)
CAM was considered an untapped resource that had a
place within healthcare. Some participants were of the
opinion that conventional healthcare was inadequate, ar-
guing that CAM fulfilled a function from a psychological
perspective. Others claimed that interest in CAM had
increased in society and that it was the right time for it.
Some expressed confidence in manual therapies, as they
believed that touch could induce well-being in patients.
I definitely believe in touch, if you feel taken care of,
you will feel better. (No. 5)
Category IV. Attitudes that constitute a barrier
This category generated the following sub-categories; re-
strictive approach, distanced view, no need of or interest
in CAM, personal definition of CAM and reticence
about CAM.
The IBD professionals described a restrictive approach
to CAM, expressing concern that patients had too much
confidence in herbal remedies. They feared that CAM
would become more popular than conventional medica-
tion, as expressed by one participant:
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CAM in place of traditional medication. (No. 4)
Several informants had a distanced view of CAM, being
uncertain about what attitude and approach to adopt and
tried to remain neutral. Only a few were sceptical al-
though many had a restrictive attitude to herbal remedies
and over-the-counter products due to experiences of side-
effects. These IBD professionals considered that CAM
was unnecessary, due to the number of effective medica-
tions available for IBD treatment. Few believed that CAM
could help patients with IBD and only one informant
expressed a specific interest in CAM. The IBD profes-
sionals found it difficult to define the concept of CAM
and one participant claimed that the terms complemen-
tary and alternative were synonymous. The concept was
regarded as diffuse and some were of the opinion that
CAM is not provided in today’s healthcare system.
I haven’t grasped whether CAM differs from or belongs
to alternative medicine. (No. 1)
The participants perceived that patients were reluctant
to talk about CAM and did not spontaneously inform
them that they used such methods. Others believed that
the reason was that patients were afraid that this infor-
mation would be treated with contempt.
I think they don’t want to make a fool of themselves in
front of the doctor by relating that they use CAM. (No. 4)
Experiences
Category I. Motives for CAM use
This category generated the sub-categories; concern
about side-effects of conventional medication, patients’
wish to avoid conventional medication, disease course,
interest, influences from the surrounding environment
and CAM provides a holistic perspective.
Several of the informants stated that an important rea-
son for IBD patients’ CAM use was that they worried
about the side-effects of conventional medication and
therefore wished to avoid such medication.
I think that many IBD patients are afraid of the
side-effects of conventional medicines. (No. 2)
The participants reported that in many cases long-
term disease and complicated disease course were the
reasons these patients tried CAM methods. They also
perceived that patients with a chronic condition more
often tried CAM to ensure that they had done every-
thing possible in order to regain health. In their view,
some of these patients were interested in CAM, which
influenced them to start using it.I think that a lot of them are very open, especially
those who are ill as they try out all avenues in order
to regain their health. (No. 6)
However, the IBD professionals also stated that CAM
use decreased when conventional treatment was satisfac-
tory. They perceived that CAM was more important
during remission than during an acute flare. The respon-
dents considered that the surrounding environment such
as the media and financial aspects influenced CAM use.
They held that the media could delude patients into be-
lieving in CAM methods that had not been evaluated
and emphasised that such methods were not subsidised
by the State. Some took the view that younger patients
seemed better informed about and more familiar with
CAM methods compared to older ones. Other factors
perceived to influence CAM use were traditional and
cultural differences. They commented that in compari-
son to Sweden, CAM was more easily accessible in other
countries and that physicians educated abroad contrib-
uted knowledge about CAM:
Half of the doctors who are qualified today were
educated outside Sweden and of course they will
contribute a great deal. (No. 4)
Some informants reported that they lacked the holistic
perspective that takes account of patients’ perceptions
and that characterises CAM, something that was missing
in traditional healthcare. One respondent commented:
CAM embodies much that has been lost in patient
care today, namely care of the whole patient. (No.1)
Category II. Perceiving patients’ quest for improvement
and well-being
This category generated the following sub-categories:
the patient is searching, the patient believes in the effi-
cacy of CAM and the patient informs about her/his
CAM use.
The IBD professionals perceived that many patients
expressed a specific interest in and asked for CAM treat-
ment. They believed that patients did everything in their
power to regain health and would try CAM sooner or
later. They also stated that patients were very interested
in CAM, believed in its efficacy and frequently asked
health professionals about it.
I think they are well aware that the drugs we provide are
quite strong and want to find an alternative, thus they
very often come and ask, is it okay to try this? (No. 7)
The participants perceived that the IBD patient group
was active in society, highly educated and ambitious. The
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patient told them about CAM use. However, the majority
perceived the patients as honest and informing them,
while some believed they were not truthful due to fear of
being disparaged by the doctor or because they had for-
gotten to inform about their CAM use. Furthermore, they
perceived that the patients had too much trust in CAM,
believing it to be harmless and without side-effects.
Many patients believe that herbal remedies are
something natural, not real medications, and good for
the body and non-toxic, which I can understand. (No. 4)
Category III. Problematic aspects
This category generated the sub-categories; limited know-
ledge/education and safety and efficacy.
The IBD professionals found it difficult to obtain
knowledge about CAM due to the large number of
CAM methods and the fact that CAM was not included
in their basic education. One informant was of the opin-
ion that no CAM education was necessary. However, the
majority reported that they lacked knowledge about
CAM. CAM was perceived as a limited area and the in-
formants would like impartial information about safety
and data on efficacy. They stressed the need for a system
to control CAM methods and the importance of design-
ing randomised control studies. One important aspect
mentioned by several of the informants was that CAM
methods must not interact with patients’ ordinary medi-
cation for treatment of an acute onset.
CAM must not interfere, interact with essential acute
treatment or delay a treatment of an underlying or a
diagnosed illness. (No. 1)
Category IV. Differing CAM experiences
This category generated the sub-categories; personal expe-
riences of CAM, influence of patients’ narratives about
CAM, experiences of friends/relatives and professional
experiences of CAM.
The informants had varying experiences of CAM.
Many had a positive personal experience of manual ther-
apies and others had relatives who had tried CAM.
I personally have positive experiences of massage and
zone therapy. (No. 6)
A number of the informants had no personal experi-
ence of CAM. However, all had experienced patients
using different CAM methods with both positive and
negative outcomes.
I have met many over the years who attended the
anthroposophic clinic. (No. 2)Discussion
This study was conducted to explore IBD professionals’ at-
titudes to and experience of CAM. The main findings re-
veal that IBD RNs and physicians had trust in and a
positive attitude to CAM, especially when used as a com-
plement to conventional medicine. The IBD professionals’
reported that patients requested and tested various CAM
methods. Despite the fact that CAM practitioners are not
considered healthcare professionals in Sweden [34], the
participants stated that CAM belonged within healthcare,
and was relevant to conventional medical care. However,
they reported attitudes that constituted a barrier, exhibited
a restrictive approach and considered CAM unnecessary,
and a few were sceptical. Despite their trust in CAM, only
one participant used CAM on a daily basis in clinical prac-
tice. Lack of congruence between attitudes and clinical
practice has previously been reported by McDowell et al.
[41]. One reason may be the participants’ perceived lack
of CAM knowledge and education, which underlines the
need for further CAM education and intervention studies
in clinical settings. Several of the participants reported
that they wished for knowledge and understanding about
CAM, which is in line with Wong et al. [42]. A German
study revealed that the majority of the participating GPs
integrated one or more CAM therapies in their everyday
clinical practice in primary healthcare [43]. In a previous
review of healthcare professionals’ attitudes towards
CAM, physicians were less positive compared to other
professional categories [44]. Although the objective of the
present study was not to assess differences between physi-
cians and RNs, nevertheless no differences in their atti-
tudes or experiences were identified.
The IBD professionals also described problematic as-
pects and expressed a critical attitude towards herbal
remedies, mainly due to lack of knowledge and the risk
of side-effects. None of the participants had any particular
knowledge of the EU directive concerning “traditional
herbal medicines” introduced in Sweden in 2006 [33].
Healthcare professionals should be aware of the potential
benefits and risks of herbal medications in addition to their
interaction with conventional medication. It is mandatory
for physicians and RNs to report all new or serious sus-
pected side-effects of conventional pharmaceutical drugs,
as well as herbal remedies, to the Swedish MPA. A review
of the reports (n = 64 493) made to the National Swedish
Pharmacovigilance system between 1987 and 2006 re-
vealed that 967 concerned suspected adverse reactions re-
lated to 175 different CAM products, some of which were
unknown and poorly documented. Considering the wide
use of CAM, the number of reports was fairly low. En-
couraging and facilitating all consumers to report adverse
events reactions should improve CAM safety monitoring
[45]. The IBD professionals in the present study stated that
a problematic aspect of CAM was the lack of regulatory
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out the gap between CAM policies and practices in
Sweden and calling for policy initiatives and dialogue [46].
The lack of CAM knowledge and education expressed
by the participants is another problematic aspect. Previ-
ous research among Swedish registered professions in
surgical care has demonstrated similar results [47]. IBD
professionals had experienced patients who had tried
various CAM methods and pointed out the importance
of guiding the patients. However, the vast majority con-
sidered themselves unqualified or lacking sufficient
knowledge of CAM to provide appropriate advice and
recommendations. In the present study, the respondents
expressed a wish for knowledge and understanding and
were interested in learning more about CAM modal-
ities. This indicates the need for CAM education for
healthcare professionals.
IBD professionals considered it vital to create trust
and a good relationship with the patient and for this rea-
son some did not ask about CAM, as they feared that such
a question could have a negative influence. A French sur-
vey revealed that 75% of IBD patients never discussed
CAM use with their IBD physicians, one reason being a
poor patient-physician relationship [21]. Richardson et al.
[48] asked patients diagnosed with cancer and their physi-
cians about the reasons for nondisclosure of CAM use
and found that both groups disagreed significantly on
every reason for nondisclosure. In response to the state-
ment “Physicians would discourage or disapprove CAM
use”, 80% of the doctors answered that this may be a rea-
son why patients do not reveal such use, while only 13%
of the patients agreed with this statement. On the other
hand, 47% of the patients stated that one reason for not
reporting CAM use was that physicians never asked [48].
However, most of the respondents in the present study be-
lieved that the majority of patients were honest about
their CAM use. To further assess these issues interviews
with IBD patients has now been conducted by our study
group. To avoid misunderstandings, it is important for
healthcare professionals to invite patients to an open dia-
logue and not criticise their patient’s decisions. What is
considered unconventional therapy today may very well
be viewed as conventional in the future.
In the present study the IBD professionals experienced
patients’ quest for improvement and well-being by means
of various CAM methods. It is essential to explore health-
care professionals’ attitudes to and experiences of CAM to
help them better respond to their patients’ needs and
wishes. The ultimate goal of healthcare is to provide qual-
ity care and improve patients’ health. Awareness of, in-
creased knowledge and education about CAM and its
implications, in addition to an understanding of how IBD
patients and healthcare providers can use CAM, will facili-
tate healthcare professionals to achieve this goal. Theresults of this study indicate that there is a need for CAM
education to be implemented in nursing and medical
school. A standard questionnaire regarding patients CAM
use may facilitate a dialogue between healthcare profes-
sionals and patients about CAM, including their CAM
use.
Methodological considerations
The participants in the present study were from the same
context, i.e., care of IBD patients, and had varying attitudes
to and experience of CAM. Generalisability of the result is
not a goal of qualitative research. Qualitative studies are
often judged on the basis of trustworthiness, which con-
cerns transferability, credibility, confirmability and depend-
ability [49]. With regard to transferability, these findings
may be applicable to other care givers in a similar context.
Transferability was enhanced by many rich descriptions of
the phenomenon. Credibility was strengthened by choosing
informants of different ages, genders and with varying pro-
fessional IBD experience. Confirmability was ensured by
interviewing physicians and RNs from two different urban
areas. To strengthen and enrich the analysis, three of the
researchers (AL, BE, LO) coded, discussed and followed up
the analysis until consensus was obtained [50]. Dependabil-
ity was achieved by becoming familiar with the data and
continuously returning to the original data to ensure that
the emerging categories and sub-categories took account of
all relevant aspects [38].
Conclusion
In Sweden IBD professionals had experienced that pa-
tients sought improvement and well-being by using CAM.
The participants had a positive attitude to and respected
their patients’ decision to use CAM. However, problem-
atic aspects were lack of knowledge and evidence in rela-
tion to CAM. IBD professionals required CAM education
to be able to meet patients’ needs and provide evidence
based knowledge. Implementing CAM education in nurs-
ing and medical schools will allow healthcare professionals
to gain an understanding of therapies widely used by
patients with IBD. The results demonstrate that IBD pro-
fessionals consider CAM an asset, but mainly as a com-
plement to conventional medical treatment. Participants
emphasised the importance of dialogue with the patients
as well as openness to patients’ interest in and wish to use
different CAM methods. What is considered unconven-
tional therapy today may very well be viewed as conven-
tional in the future.
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